Oral tranexamic acid treatment beyond 6 months for melasma patients - A retrospective case series

Kaitlyn Lam, Lam K, Danny Mansour, Mansour D, Allison Sutton, Sutton A
JAAD international · 2024 · vol. 15 , pp. 195–196 · doi:10.1016/j.jdin.2024.03.006 · PMID:38707929 · PMC11066674
Other OA: gold CC-BY-NC-ND-4.0
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-10-02 ⓘ

This retrospective case series evaluated the efficacy of oral tranexamic acid treatment for melasma patients extending beyond six months.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:44:01.284559+00:00
unpaywall
last seen: 2026-08-16T06:22:10.609676+00:00
License: CC-BY-NC-ND-4.0